-
), genome/phenotype analysis (Dr. Jihoon Kim) and applications of large language models (Dr. Ohno-Machado). The Postdoctoral Associate will be responsible for co-developing and conducting research projects
-
postdoctoral position at the interface of decision analytic modeling, pharmacoepidemiology and clinical hematology-oncology within the Section of Medical Oncology and Hematology, Department of Internal Medicine
-
. Experience working with rodent models is preferred but not required. The successful candidate should have excellent oral and written communication skill, be highly motivated for career development in
-
models, evaluation of individualized predictions or estimates for individuals with diverse backgrounds, and promotion of health equity using AI models. The Postdoctoral Associate will be responsible for co
-
, families), conduct school-based research, and maintain school relations Excellent statistics skills, including experience with longitudinal data analysis and multi-level modeling Excellent communication
-
cell and molecular biology in human cell models, cancer biology, and genomics. Experience in genomic instability, DNA damage/repair, and mutagenesis is beneficial. Computational experience is highly
-
the cell intrinsic immune machinery and DNA damage and repair processes using in vitro cell models, genetic screens (such as CRISPR and RNA interference), and animal models. We have a strong translational
-
from clinical research to molecular studies in mouse models of disease. Training/Mentoring: The postdoctoral associate will have the opportunity to gain experience with in clinical and basic research
-
, cellular biology and signaling, and mouse models of disease, enhancing our understanding of how the allosteric site influences physiology and disease mechanisms. We plan to utilize drug discovery to identify
-
in immunology and / or cancer biology research and the development of new cancer therapies. Experience with in vivo immunotherapy models, mRNA therapeutics, functional genomics and the use of CRISPR